<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">World J Surg Oncol</journal-id>
      <journal-id journal-id-type="iso-abbrev">World J Surg Oncol</journal-id>
      <journal-title-group>
        <journal-title>World Journal of Surgical Oncology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1477-7819</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26419235</article-id>
      <article-id pub-id-type="pmc">4588683</article-id>
      <article-id pub-id-type="publisher-id">711</article-id>
      <article-id pub-id-type="doi">10.1186/s12957-015-0711-6</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Primary malignant lymphoma combined with clinically &#x201C;silent&#x201D; pheochromocytoma in the same adrenal gland</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2028-5878</contrib-id>
          <name>
            <surname>Babinska</surname>
            <given-names>Anna</given-names>
          </name>
          <address>
            <phone>+48 58 349 28 40</phone>
            <email>a.mail@wp.pl</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Peksa</surname>
            <given-names>Rafa&#x142;</given-names>
          </name>
          <address>
            <phone>+48 58 349 37 40</phone>
            <email>peksarafal@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sworczak</surname>
            <given-names>Krzysztof</given-names>
          </name>
          <address>
            <phone>+48 58 349 28 40</phone>
            <email>ksworczak@gumed.edu.pl</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Endocrinology and Internal Medicine, Medical University of Gdansk, ul. D&#x119;binki 7, 80-288 Gda&#x144;sk, Poland </aff>
        <aff id="Aff2"><label/>Department of Pathology, Medical University of Gdansk, ul. D&#x119;binki 7, 80-288 Gda&#x144;sk, Poland </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>30</day>
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>13</volume>
      <elocation-id>289</elocation-id>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>5</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>9</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Babinska et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>An increased number of adrenal tumors are now diagnosed due to the increased number of abdominal CT scans being performed. We present the first case of malignant lymphoma combined with clinically &#x201C;silent&#x201D; pheochromocytoma in the same adrenal gland. An abdominal CT scan demonstrates unilateral adrenal lesion which suggests pheochromocytoma or adrenal carcinoma. Laboratory examinations revealed a slight increase of 24-h urine vanillylmandelic acid and 24-h urinary methanephrine excretion. Histological examination revealed two intermingled tumor cell proliferations&#x2014;diffuse B cell lymphoma and pheochromocytoma.</p>
        <p>Unexpected coexistence of catecholamine-producing tumor with the other adrenal lesion can lead to serious complications of diagnosis and treatment. The adequate preparation for surgery can protect patient from threatening catecholamine crisis.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Adrenal lymphoma</kwd>
        <kwd>Pheochromocytoma</kwd>
        <kwd>Treatment</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Lymphoma may occasionally involve the adrenal glands, but primary adrenal lymphoma (PAL) is very rare [<xref ref-type="bibr" rid="CR1">1</xref>]. Autopsy studies have revealed that 25&#xA0;% of patients with non-Hodgkin&#x2019;s lymphoma have involvement of the adrenal gland during their disease. However, lymphomas originating from the endocrine glands account for only 3&#xA0;% of extra nodal lymphomas and usually appear only in the thyroid gland [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>].</p>
      <p>Combined adrenal neoplasms are also rare entities. We report herein, to the best of our knowledge, the first case of collision tumor composed of a primary adrenal lymphoma and a clinically &#x201C;silent&#x201D; pheochromocytoma.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 57-year-old man was admitted to the emergency department of Medical University of Gdansk with right abdominal pain suggesting cholelithiasis. There was a history of nausea, fatigue, and weight loss of 10&#xA0;kg in the last 3&#xA0;months. The patient had no other medical history.</p>
      <p>Primary physical examination revealed a normal blood pressure of 130/70&#xA0;mmHg, pulse of 90/min, and no fever. The abdominal examination revealed a painful mass in the right side without hepatosplenomegaly. Neither signs of hypercortisolism nor lymphadenopathy were found.</p>
      <p>A contrast enhanced computer tomography (CT) was performed and showed a 13.2&#x2009;&#xD7;&#x2009;11&#xA0;cm solid right adrenal mass. The mass was homogenous with high Housfield score (51&#xA0;HU) in basic condition, and contrast washout rate was 30&#xA0;% after 10&#xA0;min. No other abdominal lesions or lymphadenopathy were detected. Initial laboratory findings revealed a normal complete blood count, but erythrocyte sedimentation rate (ESR) was 74&#xA0;mm/h (N, 0&#x2013;20&#xA0;mm/h), C-reactive protein (CRP) was 48&#xA0;mg/L (N, 0&#x2013;6&#xA0;mg/L), and lactate dehydrogenase (LDH) was 240&#xA0;IU/L (N, 105&#x2013;240&#xA0;IU/L). Hormonal laboratory tests showed a 24-h urine vanillylmandelic acid (VMA) excretion of 10.2&#xA0;mg/24&#xA0;h (N, 4&#x2013;8&#xA0;mg/24&#xA0;h) and a 24-h urinary methanephrine excretion of 395&#xA0;&#x3BC;g/24&#xA0;h (N, &lt;350 &#x3BC;g/24&#xA0;h). Serum androstendione was slightly elevated to 4.58&#xA0;ng/mL (N, 0.3&#x2013;3.5&#xA0;ng/mL) (see Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Laboratory results of presenting patient</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Disease</th><th>Androstendione</th><th>DHEA-S</th><th>Cortisol urinary excretion</th><th>Cortisol 8.00 a.m./8.00 p.m.</th><th>ACTH 8.00/20.00</th><th>VMA/metanephrine daily urinary excretion</th><th>ESR</th><th>CRP</th><th>LDH</th></tr></thead><tbody><tr><td>Basal</td><td>4.58</td><td>33.7</td><td>140</td><td>332/133</td><td>13/&lt;10</td><td>10.2/395</td><td>74</td><td>48</td><td>240</td></tr><tr><td>Progression</td><td>&#x2013;</td><td>&#x2013;</td><td>&#x2013;</td><td>149/&#x2013;</td><td>102/&#x2013;</td><td>&#x2013;/254</td><td>98</td><td>57</td><td>&#x2013;</td></tr></tbody></table><table-wrap-foot><p>Normal ranges: serum LDH, 105&#x2013;240&#xA0;IU/L; serum androstendione, 0.3&#x2013;3.5&#xA0;ng/mL; serum DHEA-S, 34&#x2013;430&#xA0;&#x3BC;g/dL; 24-h cortisol urinary excretion, 12&#x2013;486&#xA0;nmol/24h; serum cortisol: 8.00 a.m. 101&#x2013;536&#xA0;nmol/dL; plasma ACTH, 15&#x2013;46&#xA0;pg/mL; 24-h metanephrines excretion, &lt;350&#xA0;&#x3BC;g/24h; 24-h vanillylmandelic acid (VMA) excretion, 4&#x2013;8&#xA0;mg/24h; serum erythrocyte sedimentation rate (ERS), 0&#x2013;20&#xA0;mm/h; serum C-reactive protein (CRP), 0&#x2013;6&#xA0;mg/L</p></table-wrap-foot></table-wrap></p>
      <p>The results of hormonal and image findings firstly suggested malignant adrenal lesion or pheochromocytoma (PHEO) and were not suggestive of lymphoma. A slight increase of catecholamine level with the absence of clinical symptoms of PHEO inclined us to small doses of alpha-blockers only&#x2014;doxazosin 4&#xA0;mg/24&#xA0;h per os to control paroxysmal blood pressure rise during the surgery. Consequently, the patient underwent open right adrenalectomy. The mass was found to press the neighboring organs and vessels without evident infiltration. The tumor resection with right nephrectomy was performed.</p>
      <sec id="Sec3">
        <title>Pathological findings</title>
        <p>Macroscopically gray creamy tumor measuring up to 7&#xA0;cm in greatest dimension was found in the right adrenal gland infiltrating periadrenal adipose tissue and the cortical part of the kidney. Renal parenchyma infiltration measured up to 3.5&#xA0;cm.</p>
        <p>Gross lesion found in a section of the gland consisted of two parts: gray creamy tumor which destroyed the adrenal gland and the yellowish-brown spherical focus 1.8&#xA0;cm in diameter which adheres to the adrenal mass. Adrenal tumor infiltrates periadrenal adipose tissue and the cortical part of the kidney (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Pheochromocytoma is present on the left with a diffuse area of the right. The diffuse area is comprised predominantly of large lymphoid cells, so a separate diagnosis of DLBCL is made (<bold>a</bold>, magnification &#xD7;2). Adrenal tumor infiltrates periadrenal adipose tissue and the cortical part of kidney (<bold>b</bold>, magnification &#xD7;10)</p></caption><graphic xlink:href="12957_2015_711_Fig1_HTML" id="MO1"/></fig></p>
        <p>Microscopically, samples from the adrenal tumor revealed diffuse large B cell lymphoma (DLBCL) with the following immunophenotype: CD20(+), CD45(+), CD3(&#x2212;), Ki67-50&#xA0;%, CD5(&#x2212;), CD10(&#x2212;), BCL6(&#x2212;), MUM1(&#x2212;), and cyclin D1(&#x2212;) (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). Lymphoma infiltration exceeded the adrenal capsule and infiltrated adipose tissue and renal parenchyma. The microscopic picture of brown focus was consistent with the diagnosis of pheochromocytoma (chromogranin A(+) and S-100(+); Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>In the immunohistological study, tumor cells were positive for leukocyte antigen CD20(+) (<bold>b</bold>, magnification &#xD7;10) and CD45(+) (<bold>c</bold>, magnification &#xD7;2), and focus of pheochromocytoma was positive for chromogranin A(+) (<bold>a</bold>, magnification &#xD7;2) and S-100 (<bold>d</bold>, magnification &#xD7;20)</p></caption><graphic xlink:href="12957_2015_711_Fig2_HTML" id="MO2"/></fig></p>
        <p>Conclusion: microscopic examination revealed DLBCL and 1.8&#xA0;cm focus of PHEO.</p>
      </sec>
      <sec id="Sec4">
        <title>Post-operative course</title>
        <p>Before the therapy began, whole body CT scans and bone marrow aspiration biopsy was obtained. The absence of any lymphadenopathy and no bone marrow involvement ruled out a secondary lymphoma. The patient received chemotherapy: cyclophosphamide (750&#xA0;mg/m<sup>2</sup>), doxorubicin (50&#xA0;mg/m<sup>2</sup>), vincristine (1.4&#xA0;mg iv), and prednisolone (100&#xA0;mg po).</p>
        <p>After a period of 3&#xA0;months, a control CT scan showed progression of the disease with further enlargement of the left adrenal mass 11&#x2009;&#xD7;&#x2009;10&#x2009;&#xD7;&#x2009;15&#xA0;cm. The mass was homogenous and HU score was high. The 24-h urinary excretion of metabolites of catecholamines was normalized to 254&#xA0;&#x3BC;g/24&#xA0;h after surgery and remained normal during the progression of the disease (see Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).</p>
        <p>Laboratory examination showed hyponatremia&#x2014;sodium level of 129&#xA0;mmol/L (N, 137&#x2013;145&#xA0;mmol/L) and potassium level of 4.93&#xA0;mmol/L (N, 3.6&#x2013;5.0&#xA0;mmol/L). Due to the symptoms of hypotension, hyponatremia, and neoplasm enlargement of the left adrenal gland, adrenal insufficiency was suspected. The baseline serum cortisol was 149&#xA0;nmol/L (N, 101&#x2013;536&#xA0;nmol/L), and serum ACTH was elevated to 102&#xA0;pg/mL (N, 15&#x2013;46&#xA0;pg/mL), which indicated a primary adrenal insufficiency (see Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). The patient was treated with intravenous hydrocortisone (100&#xA0;mg), and after the complete remission of symptoms and normalization of electrolytes, oral hydrocortisone substitution (30&#xA0;mg/day) and fludrocortisone (0.05&#xA0;mg/day) were continued. Bone marrow aspiration biopsy showed atypical lymphocyte infiltration. Chemotherapy was continued but the patient died of sepsis after 10&#xA0;months.</p>
      </sec>
    </sec>
    <sec id="Sec5" sec-type="discussion">
      <title>Discussion</title>
      <p>Lymphoma may spread to any part of the body, and involvement of the adrenals in the course of malignant lymphomas is reported in 25&#xA0;% of autopsies [<xref ref-type="bibr" rid="CR1">1</xref>]. PAL is a rare neoplastic disease, and only 187 cases have been reported in the literature so far [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR5">5</xref>].</p>
      <p>Autoimmune adrenalitis has been proposed as an etiology of PAL [<xref ref-type="bibr" rid="CR3">3</xref>]. Immune dysfunction such as history of cancer (15&#xA0;%), human immunodeficiency virus (HIV, 4&#xA0;%), Epstein Barr virus infection, or autoimmune disorder (13&#xA0;%) may be a predisposing factor in same patients [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
      <p>Combined adrenal neoplasms are very rare [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Most published cases describe pheochromocytoma coexisting with ganglioneuroma or ganglioneuroblastoma [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Occasionally, PHEO with malignant peripheral nerve sheath tumor was identified [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. A collision tumor comprising a primary adrenal lymphoma and subclinical PHEO has never been reported before.</p>
      <p>PAL usually manifests itself with bilateral, large masses, sometimes accompanied by adrenal insufficiency [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Among clinical symptoms are fever, weight loss, and local pain [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. In the described case, PAL was diagnosed with abdominal pain and no clinical symptoms of &#x201C;silent&#x201D; pheochromocytoma.</p>
      <p>Although imaging modalities help in the diagnosis of the adrenal mass, making a firm diagnosis is difficult particularly in unilateral involvement. Fine needle aspiration biopsy or adrenalectomy is performed when histopathological diagnosis is required [<xref ref-type="bibr" rid="CR6">6</xref>].</p>
      <p>Over 12&#xA0;% of patients with incidentally found pheochromocytoma may be asymptomatic and normotensive, so all patients with adrenal incidentaloma should undergo biochemical testing for pheochromocytoma [<xref ref-type="bibr" rid="CR6">6</xref>]. Normal results of 24-h urinary metanephrine excretion rule out PHEO [<xref ref-type="bibr" rid="CR6">6</xref>].</p>
      <p>Unexpected coexistence of PHEO with the other adrenal lesion can lead to serious complications of potential biopsy, in cases of suspicion of metastases or PML [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. These procedures provided in patient with pheochromocytoma may cause life threatening catecholamine crisis and should be performed after exclusion of PHEO [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>].</p>
      <p>Many drags can cause adverse reaction in patients with PHEO. Glucocorticoids can induce catecholamine synthesis in PHEO cell culture, inducing catecholamine biosynthetic enzymes and increase the release of catecholamines from perfused canine adrenal glands [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Glucocorticoids should be avoided or administered with vigilance in patients suspected of PHEO [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
      <p>In spite of absence of clinical symptoms of PHEO, compared to a slight increase of the 24-h urinary catecholamine excretion, we withdraw from the adrenal biopsy and dexamethasone suppression test.</p>
      <p>Most authors recommend surgery for hormonal active adrenal tumors or tumors larger than 4&#xA0;cm [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. In this case, several preoperative findings were suggestive of primary malignant adrenal neoplasm: production of adrenal androgens (androstendione) and tumor size &gt;4&#xA0;cm with delayed contrast washout in CT scan (less than 50&#xA0;% after 10&#xA0;min).</p>
      <p>Hormonal suspicion of PHEO inclined us to pharmacological treatment before surgery.</p>
      <p>Any patient with suspected PHEO should undergo preoperative alfa&#x2014;adrenergic receptor blockade [<xref ref-type="bibr" rid="CR11">11</xref>]. Adequate preparation for surgery aims at lowering blood pressure, slowing down the heart rate, and controlling paroxysmal blood pressure rise and other features of catecholamine overload [<xref ref-type="bibr" rid="CR11">11</xref>]. Consequently, we qualified our patient for open adrenalectomy. Surgery is mainly used to obtain the pathological tissue for diagnosis and does not affect the prognosis in PML [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR11">11</xref>].</p>
      <p>The two most common WHO 2008-defined PAL subtypes are DLBCL&#x2014;78&#xA0;% and peripheral T cell lymphoma&#x2014;7&#xA0;% [<xref ref-type="bibr" rid="CR1">1</xref>]. Histopathological examination of our patient revealed DLBCL with the unexpected focus of clinically &#x201C;silent&#x201D; pheochromocytoma.</p>
      <p>Most patients with PAL have bilateral disease on admission, and most of them have adrenal insufficiency subsequent to destruction of more than 90&#xA0;% of adrenal parenchyma by the disease [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Because of unilateral adrenal involvement, the adrenal function was normal in the early phase. Due to disease progression, here, symptoms of adrenal insufficiency appeared after 3&#xA0;months. The proper blood pressure and lack of other symptoms of adrenal insufficiency in the initial period of the disease could be associated with presence of normal adrenal parenchyma in the other gland.</p>
      <p>Most patients with PAL have a limited time of survival. It has been reported in the literature that advanced age, primary adrenal insufficiency, tumor size, LDH, and serum soluble interleukin-2 receptor level (sIL-2R) and involvement of other organs are poor prognostic indicators [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Unilateral adrenal lymphoma may have a longer survival rate [<xref ref-type="bibr" rid="CR3">3</xref>]. Complete remissions have been reported only in few cases [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>].</p>
    </sec>
    <sec id="Sec6" sec-type="conclusion">
      <title>Conclusions</title>
      <p>PAL should be kept in mind in the differential diagnosis of patients with unilateral adrenal masses without nodal involvement in the absence of other malignancies [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Unexpected coexistence of catecholamine-producing tumor complicates diagnosis based on adrenal biopsy [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. The adequate preparation for surgery can protect patient from threatening catecholamine crisis [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR15">15</xref>].</p>
      <p>To the best of our knowledge, PAL and PHEO coexistence in one adrenal gland has never been described.</p>
    </sec>
    <sec id="Sec7">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patients for publication of this report and any accompanying images.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>AB is first author and reviewed the medical record, drafted the manuscript and researched the relevant literature. RP was involved in acquisition of data and preparing the figures. KS proofread and revised the manuscript. All authors approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rashidi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>SI</given-names>
            </name>
          </person-group>
          <article-title>Primary adrenal lymphoma: a systematic review</article-title>
          <source>Ann Hematol</source>
          <year>2013</year>
          <volume>92</volume>
          <issue>12</issue>
          <fpage>1583</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="doi">10.1007/s00277-013-1812-3</pub-id>
          <pub-id pub-id-type="pmid">23771429</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Talwalkar</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Shaheen</surname>
              <given-names>SP</given-names>
            </name>
          </person-group>
          <article-title>A case of primary unilateral adrenal Burkitt-like large cell lymphoma presenting as adrenal insufficiency</article-title>
          <source>Ann Diagn Pathol</source>
          <year>2007</year>
          <volume>11</volume>
          <issue>2</issue>
          <fpage>127</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="doi">10.1016/j.anndiagpath.2005.12.009</pub-id>
          <pub-id pub-id-type="pmid">17349573</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ezer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Parlakg&#xFC;m&#xFC;&#x15F;</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kocer</surname>
              <given-names>NE</given-names>
            </name>
            <name>
              <surname>Colako&#x11F;lu</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nursal</surname>
              <given-names>GN</given-names>
            </name>
            <name>
              <surname>Yildirim</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Primary adrenal non-Hodgkin&#x2019;s lymphoma: report of two cases</article-title>
          <source>Turk J Gastroenterol</source>
          <year>2011</year>
          <volume>22</volume>
          <issue>6</issue>
          <fpage>643</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">22287414</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dasararaju</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Avery</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Primary adrenal lymphoma with paraneoplastic syndrome</article-title>
          <source>N Am J Med Sci</source>
          <year>2013</year>
          <volume>5</volume>
          <issue>12</issue>
          <fpage>721</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.4103/1947-2714.123275</pub-id>
          <pub-id pub-id-type="pmid">24404557</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="other">Holm J, Breum L, Stenfeldt K, Friberg Hitz M. Bilateral primary adrenal lymphoma presenting with adrenal insufficiency. Case Rep Endocrinol. 2012;638298. doi:10.1155/2012/638298. Epub 2012 Sep 4.</mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arnaldi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bascaro</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Adrenal incidentaloma</article-title>
          <source>Best Pract Res Clin Endocrinol Metab</source>
          <year>2012</year>
          <volume>26</volume>
          <fpage>405</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="doi">10.1016/j.beem.2011.12.006</pub-id>
          <pub-id pub-id-type="pmid">22863384</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosas</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Kasperlik-Zaluska</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Papierska</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bass</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Pacak</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Eisenhower</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of literature</article-title>
          <source>Eur J Endocrinol</source>
          <year>2008</year>
          <volume>158</volume>
          <issue>3</issue>
          <fpage>423</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1530/EJE-07-0778</pub-id>
          <pub-id pub-id-type="pmid">18299478</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <mixed-citation publication-type="other">Barrett C, van Uum SH, Lenders JW. Risk of catecholaminergic crisis following glucocorticoid administration in patients with an adrenal mass: a literature review. Clin Endocrinol (Oxf). 2015 May 5. doi:10.1111/cen.12813. [Epub ahead of print</mixed-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>DeLellis</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lloyd</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Heitz</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Eng</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Pathology and genetics tumors of endocrine organs</article-title>
          <source>WHO Classification of Tumours, volumen 8</source>
          <year>2004</year>
          <edition>3</edition>
          <publisher-loc>Lyon</publisher-loc>
          <publisher-name>IARC</publisher-name>
          <fpage>120</fpage>
          <lpage>7</lpage>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Babi&#x144;ska</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Siekierska-Hellmann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>B&#x142;aut</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lewczuk</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wi&#x15B;niewski</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gnaci&#x144;ska</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hormonal activity in clinically silent adrenal incidentalomas</article-title>
          <source>Arch Med Sci</source>
          <year>2012</year>
          <volume>8</volume>
          <fpage>97</fpage>
          <lpage>103</lpage>
          <pub-id pub-id-type="doi">10.5114/aoms.2012.27288</pub-id>
          <pub-id pub-id-type="pmid">22457682</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bittner</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brunt</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Evaluation and management of adrenal incidentaloma</article-title>
          <source>J Surg Oncol</source>
          <year>2012</year>
          <volume>106</volume>
          <fpage>557</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="doi">10.1002/jso.23161</pub-id>
          <pub-id pub-id-type="pmid">22623268</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kasperlik-Zaluska</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Otto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cichocki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Roslonowska</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sowi&#x144;ska-Srzednicka</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jeska</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Incidentally discovered adrenal tumors: a lesson from observation of 1444 patients</article-title>
          <source>Horm Metab Res</source>
          <year>2008</year>
          <volume>40</volume>
          <fpage>338</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="doi">10.1055/s-2008-1073167</pub-id>
          <pub-id pub-id-type="pmid">18491253</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kacem</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zriba</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lakhal</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Bouteraa</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Aissaoui</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Amor</surname>
              <given-names>RB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary adrenal lymphoma</article-title>
          <source>Turk J Hemathol</source>
          <year>2014</year>
          <volume>31</volume>
          <fpage>188</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="doi">10.4274/tjh.2012.0125</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bouchikhi</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Tazi</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Amiroune</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Mellas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>El Ammari</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Khallouk</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary bilateral non-Hodgkin&#x2019;s lymphoma of the adrenal gland: a case report</article-title>
          <source>Case Rep Urol</source>
          <year>2012</year>
          <volume>2012</volume>
          <fpage>325675</fpage>
          <pub-id pub-id-type="pmid">23304624</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>&#xC7;al&#x131;&#x15F;kan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yencilek</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Large B-cell lymphoma mimicking adrenal pheochromocytoma</article-title>
          <source>Indian J Med Res</source>
          <year>2013</year>
          <volume>138</volume>
          <issue>2</issue>
          <fpage>276</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">24056610</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
